Koninklijke Philips Total Assets 2010-2024 | PHG

Koninklijke Philips total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Koninklijke Philips total assets for the quarter ending September 30, 2024 were $31.741B, a 9.18% decline year-over-year.
  • Koninklijke Philips total assets for 2024 were $31.355B, a 1.48% decline from 2023.
  • Koninklijke Philips total assets for 2023 were $31.826B, a 1.57% decline from 2022.
  • Koninklijke Philips total assets for 2022 were $32.333B, a 11.73% decline from 2021.
Koninklijke Philips Annual Total Assets
(Millions of US $)
2024 $31,355
2023 $31,826
2022 $32,333
2021 $36,630
2020 $31,657
2019 $30,258
2018 $30,728
2017 $28,614
2016 $35,747
2015 $34,396
2014 $37,688
2013 $35,278
2012 $37,399
2011 $40,344
2010 $42,853
2009 $42,573
Koninklijke Philips Quarterly Total Assets
(Millions of US $)
2024-06-30 $31,741
2023-06-30 $32,173
2023-03-31 $0
2022-06-30 $34,576
2021-06-30 $34,949
2020-06-30 $30,262
2019-06-30 $29,620
2018-06-30 $29,605
2017-06-30 $32,378
2016-12-31 $35,747
2016-09-30 $34,480
2016-06-30 $35,120
2016-03-31 $32,828
2015-12-31 $34,396
2015-09-30 $33,588
2015-06-30 $34,167
2015-03-31 $35,885
2014-12-31 $37,688
2014-09-30 $37,047
2014-06-30 $35,199
2014-03-31 $35,597
2013-12-31 $35,278
2013-09-30 $36,197
2013-06-30 $36,075
2013-03-31 $37,944
2012-12-31 $37,399
2012-09-30 $36,387
2012-06-30 $37,536
2012-03-31 $38,851
2011-12-31 $40,344
2011-09-30 $39,236
2011-06-30 $39,052
2011-03-31 $40,982
2010-12-31 $42,853
2010-09-30 $41,868
2010-06-30 $43,788
2010-03-31 $44,166
2009-12-31 $42,573
2009-09-30 $41,983
2009-06-30 $39,559
2009-03-31 $41,534
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.066B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.816B 27.87
Boston Scientific (BSX) United States $152.176B 38.10
Stryker (SYK) United States $145.393B 30.40
EssilorLuxottica (ESLOY) France $127.544B 0.00
Medtronic (MDT) Ireland $107.067B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.941B 0.00
Haleon (HLN) United Kingdom $48.416B 27.54
ResMed (RMD) United States $35.930B 26.99
GE HealthCare Technologies (GEHC) United States $31.992B 15.19
Agilent Technologies (A) United States $30.486B 20.14
Terumo (TRUMY) Japan $28.205B 0.00
Insulet (PODD) United States $21.859B 85.82
Zimmer Biomet Holdings (ZBH) United States $18.837B 12.10
Baxter (BAX) United States $15.857B 11.84
Smith & Nephew SNATS (SNN) United Kingdom $12.412B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.030B 0.00
Bio-Rad Laboratories (BIO) United States $6.686B 22.60
Lantheus Holdings (LNTH) United States $5.655B 14.27
Prestige Consumer Healthcare (PBH) United States $4.325B 19.27
Perrigo (PRGO) Ireland $3.713B 9.41
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.426B 14.92
ICU Medical (ICUI) United States $3.404B 25.10
Envista Holdings (NVST) United States $2.981B 24.77
QuidelOrtho (QDEL) United States $2.458B 16.90
GN Store Nord (GNNDY) Denmark $2.075B 17.18
LeMaitre Vascular (LMAT) United States $1.813B 40.53
AtriCure (ATRC) United States $1.534B 0.00
Neogen (NEOG) United States $1.296B 16.58
Green Thumb Industries (GTBIF) United States $1.173B 26.38
Kestra Medical Technologies (KMTS) United States $1.164B 0.00
AdaptHealth (AHCO) United States $1.156B 11.75
BioLife Solutions (BLFS) United States $1.106B 0.00
InMode (INMD) Israel $1.005B 9.20
Phibro Animal Health (PAHC) United States $0.910B 11.64
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.577B 0.00
Curaleaf Holdings (CURLF) Canada $0.557B 0.00
Owens & Minor (OMI) United States $0.542B 4.49
Valneva SE (VALN) France $0.541B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.504B 0.00
Tilray Brands (TLRY) Canada $0.431B 0.00
Surmodics (SRDX) United States $0.383B 0.00
Omeros (OMER) United States $0.360B 0.00
Cresco Labs (CRLBF) United States $0.358B 0.00
SNDL (SNDL) Canada $0.339B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Capricor Therapeutics (CAPR) United States $0.290B 0.00
Sanara MedTech (SMTI) United States $0.288B 0.00
VAREX IMAGING (VREX) United States $0.283B 10.42
Aurora Cannabis (ACB) Canada $0.273B 48.50
Sanuwave Health (SNWV) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.250B 21.07
Verano Holdings (VRNOF) United States $0.248B 0.00
Cerus (CERS) United States $0.247B 0.00
ZimVie (ZIMV) United States $0.244B 11.09
Canopy Growth (CGC) Canada $0.241B 0.00
Biote (BTMD) United States $0.219B 6.15
Quanterix (QTRX) United States $0.205B 0.00
High Tide (HITI) Canada $0.194B 0.00
OraSure Technologies (OSUR) United States $0.188B 0.00
Utah Medical Products (UTMD) United States $0.176B 14.18
Brainsway (BWAY) Israel $0.164B 51.24
TriSalus Life Sciences (TLSI) United States $0.162B 0.00
Organigram Global (OGI) Canada $0.158B 0.00
FitLife Brands (FTLF) United States $0.147B 18.16
Jin Medical (ZJYL) China $0.130B 0.00
TerrAscend (TSNDF) Canada $0.110B 0.00
Exagen (XGN) United States $0.103B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
MacroGenics (MGNX) United States $0.090B 0.00
Agape ATP (ATPC) $0.078B 0.00
Fonar (FONR) United States $0.077B 10.77
Veru (VERU) United States $0.074B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
InterCure (INCR) Israel $0.072B 0.00
Zynex (ZYXI) United States $0.063B 0.00
United Health Products (UEEC) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.046B 0.00
Apyx Medical (APYX) United States $0.044B 0.00
Modular Medical (MODD) United States $0.041B 0.00
Rockwell Medical (RMTI) United States $0.038B 56.00
United-Guardian (UG) United States $0.037B 12.79
Safety Shot (SHOT) United States $0.037B 0.00
Nephros (NEPH) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
Innovative Eyewear (LUCY) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00